ISENTRESS (Merck Sharp & Dohme Corp.)


Welcome to the PulseAid listing for the ISENTRESS drug offered from Merck Sharp & Dohme Corp.. This HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Merck Sharp & Dohme Corp.
NON-PROPRIETARY NAME: RALTEGRAVIR
SUBSTANCE NAME: RALTEGRAVIR POTASSIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: GRANULE, FOR SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-12-20
END MARKETING DATE: 0000-00-00


ISENTRESS HUMAN PRESCRIPTION DRUG Details:

Item DescriptionISENTRESS from Merck Sharp & Dohme Corp.
LABELER NAME: Merck Sharp & Dohme Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2013-12-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0006-3603_dea5d8a6-af2b-46c0-ba65-3a3f7b2fd1ec
PRODUCT NDC: 0006-3603
APPLICATION NUMBER: NDA205786

Other RALTEGRAVIR POTASSIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalISENTRESS
DIRECT RXISENTRESS
Dispensing Solutions, Inc.ISENTRESS
H.J. Harkins Company Inc.ISENTRESS
Merck Sharp & Dohme Corp.ISENTRESS
NuCare Pharmaceuticals,Inc.ISENTRESS
Physicians Total Care, Inc.ISENTRESS
RedPharm Drug, Inc.ISENTRESS
REMEDYREPACK INC.ISENTRESS
State of Florida DOH Central PharmacyISENTRESS